8-K: Flora Growth Corp. Enters At-The-Market Offering Agreement with Aegis Capital Corp.

Flora Growth Corp. has entered into an agreement with Aegis Capital Corp. to potentially sell up to $3.794 million of its common shares through an at-the-market offering.

Summary

• Flora Growth Corp. has signed an At-The-Market Issuance Sales Agreement with Aegis Capital Corp., allowing the company to sell common shares from time to time.
• The maximum amount of shares that can be sold under this agreement is capped at $3.794 million or the company's maximum offering amount permitted under its current shelf registration.
• Aegis Capital Corp. will act as the sales agent and will receive a commission of up to 3.0% of the gross proceeds from each sale.
• The company is not obligated to sell any shares under this agreement and can suspend or terminate the offering at any time.
• The shares will be sold through an at-the-market offering, which means they will be sold at prevailing market prices.
• The agreement includes standard indemnification clauses, protecting Aegis from certain liabilities.
• The offering will be made under the company's existing registration statement filed on Form S-3.

Sentiment

Score: 6

Explanation: The document is neutral to slightly positive. It outlines a standard financial transaction that provides the company with a flexible way to raise capital, but also carries the risk of dilution.

Positives

• The agreement provides Flora Growth Corp. with a flexible way to raise capital.
• The at-the-market offering allows the company to sell shares at prevailing market prices.
• The company is not obligated to sell shares, giving them control over the timing and amount of any sales.
• The agreement includes standard indemnification clauses, protecting both parties.

Negatives

• The sale of shares could dilute existing shareholders' ownership.
• The company will incur fees of up to 3.0% of the gross proceeds from each sale.
• There is no guarantee that the company will be able to sell all of the shares it intends to sell.

Risks

• The company's share price could be negatively impacted by the sale of new shares.
• The company may not be able to raise the full $3.794 million if market conditions are unfavorable.
• The company's financial performance could be negatively impacted if it is unable to effectively use the capital raised.

Future Outlook

The company has the option to sell common shares through Aegis Capital Corp. at its discretion, with no obligation to sell any specific amount. The agreement provides flexibility for future capital raising activities.

Management Comments

• The document does not contain any direct quotes from management.

Industry Context

At-the-market offerings are a common method for publicly traded companies to raise capital. This agreement allows Flora Growth Corp. to access the market for funds without a traditional underwritten offering.

Comparison to Industry Standards

• At-the-market offerings are a common practice for companies seeking flexible capital raising options.
• The 3.0% commission is within the typical range for such agreements.
• The $3.794 million cap is relatively small, suggesting a targeted approach to capital raising.
• Comparable companies in the cannabis sector have also used ATM offerings to raise capital, such as Tilray and Canopy Growth.

Stakeholder Impact

• Shareholders may experience dilution of their ownership if the company sells a significant number of shares.
• The company may be able to fund its operations and growth plans with the capital raised.
• The agreement provides a flexible way for the company to access capital markets.

Next Steps

• Flora Growth Corp. may begin selling common shares through Aegis Capital Corp. at its discretion.
• The company will need to file prospectus supplements with the SEC as required.
• Aegis Capital Corp. will execute sales of shares as instructed by the company.

Key Dates

Keywords

at-the-market offering, common shares, capital raise, Aegis Capital Corp., sales agreement, equity financing, FLGC, Flora Growth Corp.